Rothschild Redburn upgrades Abbott Laboratories stock rating
Published on 10/03/2026 at 12:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Rothschild Redburn upgraded Abbott Laboratories stock from Neutral to Buy on October 2, 2026, according to an Investing.com report. Lang & Schwarz quoted Abbott Laboratories at EUR 86.53 in weekend trading at 12:22 p.m. CEST on October 3, 2026. The quote was plus 0.01 percent versus the close of EUR 86.52 at Lang & Schwarz on October 2, 2026.
Weekend trading
The Lang & Schwarz quote of EUR 86.53 was EUR 0.01 above the close of EUR 86.52 at Lang & Schwarz on October 2, 2026. The quoted change was plus 0.01 percent on that reference base. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
The last Xetra trading day
Abbott Laboratories closed at EUR 86.52 at Lang & Schwarz on October 2, 2026. The company’s primary listing is on the New York Stock Exchange under the ticker ABT, according to the Investing.com report.
Analyst rating
Investing.com reported that Rothschild Redburn raised its price target for Abbott Laboratories to USD 127 from USD 119 while changing its rating from Neutral to Buy on October 2, 2026. The firm cited expected strength in Abbott’s Medical Devices business and its cardiovascular and diabetes operations, according to the report.
SimpleScreen CRC launch
Abbott announced the U.S. commercial launch of SimpleScreen CRC on September 30, 2026. The FDA-approved blood-based colorectal cancer screening test is intended for average-risk adults age 45 and older. Abbott said the test was developed and manufactured by Freenome, is exclusively commercialized by Abbott and joins Cologuard Plus in its screening portfolio. The company said SimpleScreen CRC is covered by Medicare, with no out-of-pocket costs for eligible patients with Medicare Part B, according to the PR Newswire release.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
